UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018382 |
|---|---|
| Receipt number | R000021286 |
| Scientific Title | Phase I study of neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel for patients with borderline resectable pancreatic cancer |
| Date of disclosure of the study information | 2015/07/22 |
| Last modified on | 2017/07/01 17:26:16 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/07/22 15:30:29 | ||
| 2 | Update | 2016/06/22 16:41:43 | Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2017/01/21 15:25:43 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2017/07/01 17:26:16 | Recruitment status Publication of results |
